A compound of formula (I) wherein T represents O, S or NR and wherein R represents a H, A C.sub.1-6alkyl group or a phenyl C.sub.1-6alkyl group and pharmaceutically acceptable salts thereof, processes for preparing such compounds, their the utility in treating clinical conditions including lipid disorders (dyslipidemias) whether or not associated with insulin resistance, methods for their therapeutic use and and pharmaceutical compositions containing them.

 
Web www.patentalert.com

< Substituted 3-carbonyl-1h-indol-1-yl acetic acid derivatives as ibhibitors of plasminogen activator inhibitor-1 (PAI-1)

< Serotonin and catecholamine system segment optimization technology

> Butenoic acid derivatives processes for the preparation thereof pharmaceutical compositions comprising them and use for the treatment of dyslipidaemia atherosclerosis and diabetes

> Muscarinic agonists
~ 00282